Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence
Authors
Keywords
-
Journal
Frontiers in Molecular Biosciences
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-01-25
DOI
10.3389/fmolb.2022.836417
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiology of Triple-Negative Breast Cancer
- (2021) Frederick M. Howard et al. CANCER JOURNAL
- The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
- (2021) Sima Singh et al. DRUG DISCOVERY TODAY
- Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes
- (2021) H. Kuroda et al. Clinical & Translational Oncology
- Recent Progress on NIR-II Photothermal Therapy
- (2021) Yunguang Zhang et al. Frontiers in Chemistry
- Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review
- (2021) Sergiusz Łukasiewicz et al. Cancers
- Is There One Key Step in the Metastatic Cascade?
- (2021) Antoine M. Dujon et al. Cancers
- Mutational Landscape of Pirin and Elucidation of the Impact of Most Detrimental Missense Variants That Accelerate the Breast Cancer Pathways: A Computational Modelling Study
- (2021) Muhammad Suleman et al. Frontiers in Molecular Biosciences
- Discovery of Novel Inhibitors From Medicinal Plants for V-Domain Ig Suppressor of T-Cell Activation
- (2021) Iqra Muneer et al. Frontiers in Molecular Biosciences
- Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
- (2020) K.G.K. Deepak et al. PHARMACOLOGICAL RESEARCH
- Secondary cancer risk after radiation therapy for breast cancer with different radiotherapy techniques
- (2020) Quanbin Zhang et al. Scientific Reports
- Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer
- (2020) Rita Nanda et al. JAMA Oncology
- The effect of vitamin D supplementation on the risk of breast cancer: a trial sequential meta-analysis
- (2020) Liguang Zhou et al. BREAST CANCER RESEARCH AND TREATMENT
- Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies
- (2020) Mauricio A. Medina et al. International Journal of Environmental Research and Public Health
- Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women
- (2020) Eun Young Kim et al. CANCER
- Role of immune checkpoint inhibitors in the revolutionization of advanced melanoma care
- (2020) Sima Singh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Obesity and Breast Cancer: A Case of Inflamed Adipose Tissue
- (2020) Ryan Kolb et al. Cancers
- Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite
- (2019) Wei-Siang Liao et al. Acta Biomaterialia
- Body Mass Index at Diagnosis as a Prognostic Factor for Early-Stage Invasive Breast Cancer after Surgical Resection
- (2019) Xue Wang et al. Oncology Research and Treatment
- Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
- (2019) Aditya Bardia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Tumor Microenvironment for Cancer Therapy
- (2019) Catarina Roma-Rodrigues et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A deep learning model based on sparse auto-encoder for prioritizing cancer-related genes and drug target combinations
- (2019) Ji-Wei Chang et al. CARCINOGENESIS
- Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia
- (2019) Wijden Mahfoudh et al. Journal of Translational Medicine
- Current Landscape of Immunotherapy in Breast Cancer
- (2019) Sylvia Adams et al. JAMA Oncology
- Inherited variants in XRCC2 and the risk of breast cancer
- (2019) Wojciech Kluźniak et al. BREAST CANCER RESEARCH AND TREATMENT
- Investigating the risk of breast cancer among women exposed to chemicals: a nested case–control study using improved exposure estimates
- (2019) Cecilia Videnros et al. INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH
- Temporal trends in breast cancer survival by race and ethnicity: A population-based cohort study
- (2019) Deirdre A. Hill et al. PLoS One
- CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
- (2019) Lei Nie et al. Nature Communications
- Occupational Chemical Exposure and Breast Cancer Risk According to Hormone Receptor Status: A Systematic Review
- (2019) Veruscka Leso et al. Cancers
- Light-Activated Core–Shell Nanoparticles for Spatiotemporally Specific Treatment of Metastatic Triple-Negative Breast Cancer
- (2018) Qingshuo Meng et al. ACS Nano
- Dietary Patterns and Breast Cancer Risk: A Systematic Review
- (2018) AKHILA DANDAMUDI et al. ANTICANCER RESEARCH
- Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases
- (2018) Ruijing Liang et al. BIOMATERIALS
- Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study
- (2018) Louise E Johns et al. BRITISH JOURNAL OF CANCER
- Family History and Risk of Second Primary Breast Cancer afterIn SituBreast Carcinoma
- (2018) Michelle L. Baglia et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Inference of Transcriptional Regulation from Expression Data Using Model Integration
- (2018) Long Wang et al. Current Bioinformatics
- Breast cancer family history and allele-specific DNA methylation in the legacy girls study
- (2018) Hui-Chen Wu et al. Epigenetics
- Prognosis and outcome in CDH1-mutant lobular breast cancer
- (2018) Giovanni Corso et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer
- (2018) Tiffany A. Traina et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast Cancer in Men
- (2018) Sharon H. Giordano NEW ENGLAND JOURNAL OF MEDICINE
- The critical role of p16/Rb pathway in the inhibition of GH3 cell cycle induced by T-2 toxin
- (2018) Zainab Fatima et al. TOXICOLOGY
- Consumption of ultra-processed foods and cancer risk: results from NutriNet-Santé prospective cohort
- (2018) Thibault Fiolet et al. BMJ-British Medical Journal
- Consumption of ultra-processed foods and cancer risk: results from NutriNet-Santé prospective cohort
- (2018) Thibault Fiolet et al. BMJ-British Medical Journal
- Discovery of selective inhibitors for cyclic AMP response element-binding protein
- (2018) Iqra Muneer et al. ANTI-CANCER DRUGS
- Diet and risk of breast, endometrial and ovarian cancer: UK Women’s Cohort Study
- (2018) Yashvee Dunneram et al. BRITISH JOURNAL OF NUTRITION
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index
- (2018) Neil M. Iyengar et al. JAMA Oncology
- Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field
- (2017) Clinton Yam et al. ONCOLOGIST
- Alcohol Use and Breast Cancer: A Critical Review
- (2016) Kevin D. Shield et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
- (2016) H. Bonnefoi et al. ANNALS OF ONCOLOGY
- Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer
- (2016) Jacqueline Tsai et al. ANNALS OF SURGICAL ONCOLOGY
- Incidence and Mortality and Epidemiology of Breast Cancer in the World
- (2016) Mahshid Ghoncheh et al. Asian Pacific Journal of Cancer Prevention
- Inhibition of Sonic Hedgehog Signaling Pathway by Thiazole Antibiotic Thiostrepton Attenuates the CD44+/CD24-Stem-Like Population and Sphere-Forming Capacity in Triple-Negative Breast Cancer
- (2016) Na Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Microsatellite Instability as a Biomarker for PD-1 Blockade
- (2016) J. C. Dudley et al. CLINICAL CANCER RESEARCH
- Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6 ) in breast cancer
- (2016) Gabriele Corda et al. JOURNAL OF PATHOLOGY
- Radiation therapy for breast cancer: Literature review
- (2016) Karunakaran Balaji et al. Medical Dosimetry
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Notch signaling: its roles and therapeutic potential in hematological malignancies
- (2016) Yisu Gu et al. Oncotarget
- Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013
- (2016) Hmwe H Kyu et al. BMJ-British Medical Journal
- Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013
- (2016) Hmwe H Kyu et al. BMJ-British Medical Journal
- A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
- (2016) Akio Ohta Frontiers in Immunology
- Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes
- (2016) Sasha E. Stanton et al. JAMA Oncology
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
- (2016) Brian D. Lehmann et al. PLoS One
- Genetics of breast cancer: a topic in evolution
- (2015) S. Shiovitz et al. ANNALS OF ONCOLOGY
- Breast cancer risk associated with benign breast disease: systematic review and meta-analysis
- (2015) Sara W. Dyrstad et al. BREAST CANCER RESEARCH AND TREATMENT
- Therapeutic targets of triple-negative breast cancer: a review
- (2015) Vinayak S Jamdade et al. BRITISH JOURNAL OF PHARMACOLOGY
- Breast cancer statistics, 2015: Convergence of incidence rates between black and white women
- (2015) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Notch signaling: An emerging therapeutic target for cancer treatment
- (2015) Xun Yuan et al. CANCER LETTERS
- The effect of environmental chemicals on the tumor microenvironment
- (2015) Stephanie C. Casey et al. CARCINOGENESIS
- Obesity in breast cancer – What is the risk factor?
- (2015) F.R. James et al. EUROPEAN JOURNAL OF CANCER
- Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
- (2015) Ravi Singh et al. International Journal of Nanomedicine
- Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
- (2015) William M. Sikov et al. JOURNAL OF CLINICAL ONCOLOGY
- Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells
- (2015) Dinesh Vyas et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
- (2015) Betsy A. Kohler et al. JNCI-Journal of the National Cancer Institute
- Near infrared light-actuated gold nanorods with cisplatin–polypeptide wrapping for targeted therapy of triple negative breast cancer
- (2015) Bing Feng et al. Nanoscale
- Quantum dot-based in situ simultaneous molecular imaging and quantitative analysis of EGFR and collagen IV and identification of their prognostic value in triple-negative breast cancer
- (2015) Hong-Mei Zheng et al. TUMOR BIOLOGY
- Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6
- (2015) Yu-Chun Hsiao et al. Oncotarget
- Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
- (2015) Betsy A. Kohler et al. JNCI-Journal of the National Cancer Institute
- Effects of Age on the Detection and Management of Breast Cancer
- (2015) Andrew McGuire et al. Cancers
- Importance of a Personal History of Breast Cancer as a Risk Factor for the Development of Subsequent Breast Cancer: Results From Screening Breast MRI
- (2014) David V. Schacht et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact
- (2014) J. M. Nabholtz et al. ANNALS OF ONCOLOGY
- Juxtacrine Signaling Is Inherently Noisy
- (2014) Tomer Yaron et al. BIOPHYSICAL JOURNAL
- Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters
- (2014) Leena Hilakivi-Clarke BREAST CANCER RESEARCH
- Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case–control EpiGEICAM study
- (2014) A Castelló et al. BRITISH JOURNAL OF CANCER
- FRET Enhanced Fluorescent Nanodiamonds
- (2014) Rafal Fudala et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Colocalized Delivery of Rapamycin and Paclitaxel to Tumors Enhances Synergistic Targeting of the PI3K/Akt/mTOR Pathway
- (2014) Elvin Blanco et al. MOLECULAR THERAPY
- PI3K and cancer: lessons, challenges and opportunities
- (2014) David A. Fruman et al. NATURE REVIEWS DRUG DISCOVERY
- Minimizing second cancer risk following radiotherapy: current perspectives
- (2014) John Ng et al. Cancer Management and Research
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial
- (2013) Olöf Bjarnadottir et al. BREAST CANCER RESEARCH AND TREATMENT
- Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up
- (2013) Xuehong Zhang et al. BREAST CANCER RESEARCH AND TREATMENT
- Mechanisms Governing Metastatic Dormancy and Reactivation
- (2013) Filippo G. Giancotti CELL
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
- (2013) A. Gucalp et al. CLINICAL CANCER RESEARCH
- Bioactivity of Turmeric-derived Curcuminoids and Related Metabolites in Breast Cancer
- (2013) Laura Wright et al. CURRENT PHARMACEUTICAL DESIGN
- Effects of Alcohol on the Endocrine System
- (2013) Nadia Rachdaoui et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- The Effect of Curcumin on Breast Cancer Cells
- (2013) Dongwu Liu et al. Journal of Breast Cancer
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
- (2013) Neil E. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study
- (2013) Miguel Martín et al. JOURNAL OF CLINICAL ONCOLOGY
- Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies
- (2013) LANCET ONCOLOGY
- Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment
- (2013) Koichiro Hayashi et al. Theranostics
- The Relationship of Mammographic Density and Age: Implications for Breast Cancer Screening
- (2012) Cristina M. Checka et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- The diverse roles and clinical relevance of PARPs in DNA damage repair: Current state of the art
- (2012) Mike De Vos et al. BIOCHEMICAL PHARMACOLOGY
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- Targeting the Hedgehog signaling pathway for cancer therapy
- (2012) Yiwei Li et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Poly(Adenosine Diphosphate–Ribose) Polymerase Inhibitors in Cancer Treatment
- (2012) Sook Ryun Park et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
- (2012) Lisa A. Carey et al. JOURNAL OF CLINICAL ONCOLOGY
- Dvl2-Dependent Activation of Daam1 and RhoA Regulates Wnt5a-Induced Breast Cancer Cell Migration
- (2012) Yichao Zhu et al. PLoS One
- Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
- (2012) A. Gurney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
- (2011) Leif W. Ellisen CANCER CELL
- The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology
- (2011) Suzanne A. Eccles INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- A Monoclonal Antibody against Human Notch1 Ligand-Binding Domain Depletes Subpopulation of Putative Breast Cancer Stem-like Cells
- (2011) A. Sharma et al. MOLECULAR CANCER THERAPEUTICS
- The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings
- (2011) Thomas Helleday Molecular Oncology
- Hormone replacement therapy and the risk of breast cancer
- (2011) Steven A. Narod Nature Reviews Clinical Oncology
- Adverse Health Outcomes in Women Exposed In Utero to Diethylstilbestrol
- (2011) Robert N. Hoover et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triple-Negative Breast Cancer: An Unmet Medical Need
- (2011) C. A. Hudis et al. ONCOLOGIST
- Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
- (2010) Melinda Protani et al. BREAST CANCER RESEARCH AND TREATMENT
- CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer
- (2010) Xinhui Wang et al. JNCI-Journal of the National Cancer Institute
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers
- (2009) Sharon Nofech-Mozes et al. BREAST CANCER RESEARCH AND TREATMENT
- The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis
- (2009) Rui Benedito et al. CELL
- The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
- (2008) Jiyoung Rhee et al. BMC CANCER
- The prognostic importance of triple negative breast carcinoma
- (2008) Hakan Mersin et al. BREAST
- Impact of Triple Negative Phenotype on Breast Cancer Prognosis
- (2008) Henry G. Kaplan et al. Breast Journal
- Prognostic Value of Triple-Negative Phenotype at the Time of Locally Recurrent, Conservatively Treated Breast Cancer
- (2008) Rahul R. Parikh et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Notch3: from subtle structural differences to functional diversity
- (2008) D Bellavia et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started